DGLYX | RNPHX | DGLYX / RNPHX | |
Total Expense Ratio | 0.89 | 0.56 | 159% |
Annual Report Gross Expense Ratio | 0.89 | 0.56 | 159% |
Fund Existence | 12 years | 10 years | - |
Gain YTD | 3.288 | 10.075 | 33% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 250 | 400,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 801M | 152B | 1% |
Annual Yield % from dividends | 0.44 | 0.70 | 63% |
Returns for 1 year | -4.27 | 10.12 | -42% |
Returns for 3 years | 1.19 | 44.59 | 3% |
Returns for 5 years | -1.62 | 50.63 | -3% |
Returns for 10 years | 13.06 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
MCFGX | 18.10 | N/A | N/A |
BlackRock Capital Appreciation Inv C | |||
VEXAX | 143.33 | N/A | N/A |
Vanguard Extended Market Index Admiral | |||
BRKSX | 15.58 | N/A | N/A |
MFS Blended Research Em Mkts Eq R2 | |||
MXEVX | 11.87 | N/A | N/A |
Empower Core Strategies Intl Eq Inv | |||
EMRIX | 15.99 | -0.08 | -0.50% |
VanEck Emerging Markets I |